
        <!DOCTYPE html>
        <html>
        <head>
            <title>Rocket Pharmaceuticals Inc. (RCKT) - Articles</title>
            <meta name="viewport" content="width=device-width, initial-scale=1.0">
            <style>
                :root {
                    --primary-color: #000000;
                    --secondary-color: #666666;
                    --accent-color: #d5001c;
                    --text-color: #2c3e50;
                    --border-color: #e0e0e0;
                    --hover-color: #f8f9fa;
                }
                
                body { 
                    font-family: "Porsche Next", "Segoe UI", Arial, sans-serif;
                    margin: 0;
                    padding: 0;
                    color: var(--text-color);
                    background-color: #f5f6fa;
                    line-height: 1.6;
                }
                
                .header {
                    background: linear-gradient(135deg, #000 0%, #1a1a1a 100%);
                    padding: 25px 0;
                    box-shadow: 0 2px 10px rgba(0,0,0,0.2);
                    position: sticky;
                    top: 0;
                    z-index: 1000;
                    backdrop-filter: blur(10px);
                }
                
                .header::before {
                    content: '';
                    position: absolute;
                    top: 0;
                    left: 0;
                    right: 0;
                    bottom: 0;
                    background: radial-gradient(circle at 30% 50%, rgba(255,255,255,0.08) 0%, rgba(255,255,255,0) 70%);
                    pointer-events: none;
                }
                
                .header-content {
                    max-width: 1400px;
                    margin: 0 auto;
                    padding: 0 30px;
                    display: flex;
                    justify-content: space-between;
                    align-items: center;
                }
                
                .header-title {
                    font-size: 28px;
                    font-weight: 300;
                    color: #fff;
                    margin: 0;
                    letter-spacing: 1px;
                }
                
                .back-btn {
                    background: rgba(255,255,255,0.1);
                    border: 1px solid rgba(255,255,255,0.2);
                    padding: 10px 20px;
                    color: #fff;
                    text-decoration: none;
                    font-size: 14px;
                    border-radius: 4px;
                    transition: all 0.3s ease;
                    backdrop-filter: blur(5px);
                }
                
                .back-btn:hover {
                    background: rgba(255,255,255,0.2);
                    transform: translateY(-2px);
                }
                
                .container {
                    max-width: 1400px;
                    margin: 40px auto;
                    padding: 0 30px;
                }
                
                .stats-container {
                    display: grid;
                    grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
                    gap: 20px;
                    margin-bottom: 40px;
                }
                
                .stat-card {
                    background: #fff;
                    border-radius: 12px;
                    padding: 25px;
                    text-align: center;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: transform 0.3s ease;
                }
                
                .stat-card:hover {
                    transform: translateY(-5px);
                }
                
                .stat-value {
                    font-size: 32px;
                    font-weight: 300;
                    color: var(--primary-color);
                    margin-bottom: 10px;
                }
                
                .stat-label {
                    font-size: 14px;
                    color: var(--secondary-color);
                    text-transform: uppercase;
                    letter-spacing: 1px;
                }
                
                .articles-grid {
                    display: grid;
                    grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
                    gap: 30px;
                    margin-top: 40px;
                }
                
                .article-card {
                    background: #fff;
                    border-radius: 12px;
                    overflow: hidden;
                    box-shadow: 0 4px 20px rgba(0,0,0,0.08);
                    transition: all 0.3s ease;
                }
                
                .article-card:hover {
                    transform: translateY(-5px);
                }
                
                .article-content {
                    padding: 25px;
                }
                
                .article-title {
                    font-size: 18px;
                    font-weight: 400;
                    margin: 0 0 15px;
                    line-height: 1.4;
                }
                
                .article-title a {
                    color: var(--primary-color);
                    text-decoration: none;
                    transition: color 0.2s ease;
                }
                
                .article-title a:hover {
                    color: var(--accent-color);
                }
                
                .article-meta {
                    display: flex;
                    align-items: center;
                    gap: 20px;
                    margin-bottom: 15px;
                    font-size: 14px;
                    color: var(--secondary-color);
                }
                
                .article-sentiment {
                    padding: 4px 12px;
                    border-radius: 20px;
                    font-weight: 500;
                    font-size: 14px;
                }
                
                .article-sentiment.positive {
                    background: rgba(40,167,69,0.1);
                    color: #28a745;
                }
                
                .article-sentiment.negative {
                    background: rgba(220,53,69,0.1);
                    color: #dc3545;
                }
                
                .article-sentiment.neutral {
                    background: rgba(108,117,125,0.1);
                    color: #6c757d;
                }
                
                .article-summary {
                    font-size: 14px;
                    color: var(--text-color);
                    line-height: 1.6;
                    margin-top: 15px;
                    opacity: 0.8;
                }
                
                @media (max-width: 768px) {
                    .header-content {
                        padding: 0 20px;
                    }
                    
                    .header-title {
                        font-size: 20px;
                    }
                    
                    .container {
                        padding: 0 20px;
                        margin: 20px auto;
                    }
                    
                    .articles-grid {
                        grid-template-columns: 1fr;
                        gap: 20px;
                    }
                    
                    .stat-card {
                        padding: 20px;
                    }
                    
                    .stat-value {
                        font-size: 28px;
                    }
                }
            </style>
        </head>
        <body>
            <div class="header">
                <div class="header-content">
                    <h1 class="header-title">Rocket Pharmaceuticals Inc. (RCKT)</h1>
                    <a href="sentiment_report_latest.html" class="back-btn">‚Üê Back to Dashboard</a>
                </div>
            </div>
            
            <div class="container">
                <div class="stats-container">
                    <div class="stat-card">
                        <div class="stat-value">26</div>
                        <div class="stat-label">Total Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">6</div>
                        <div class="stat-label">Positive Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">14</div>
                        <div class="stat-label">Negative Articles</div>
                    </div>
                    <div class="stat-card">
                        <div class="stat-value">-0.29</div>
                        <div class="stat-label">Average Sentiment</div>
                    </div>
                </div>
                
                <div class="articles-grid">
        
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9d160bc9772b82fc83a02fc607c865753e1b5f428adb5b72254f2dd4f31b04d1" target="_blank" rel="noopener noreferrer">Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-07</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">NEW YORK, June 7, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rocket Pharmaceuticals, Inc. .¬†Such investors are advised to contact Danielle Peyton at......</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=9a9604491941dc839464309d58d454e941b6fdd08d42139f64496692131fdaf0" target="_blank" rel="noopener noreferrer">Harbor Health Care ETF Q1 2025 Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-06</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.48
                                </span>
                            </div>
                            <div class="article-summary">During the first quarter, the Harbor Health Care ETF returned 2.18% (NAV), outperforming the Russell 3000√Ç¬Æ Growth Health Care Index, which returned 1.99%....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=4511aa2d3e92f0d7ebe161fcc29b584b80f037a5cf9ff8c520ba4649c56baf4f" target="_blank" rel="noopener noreferrer">Harbor Small Cap Growth Fund Q1 2025 Commentary</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-06-04</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=31f15f4a04b7742d44a654664f4de7a279f18755760a01645ab35b006b7cabfc" target="_blank" rel="noopener noreferrer">Leerink Partners Downgrades Rocket Pharmaceuticals (RCKT) to Market Perform on Danon Disease Blow</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-29</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc.‚Äôs (NASDAQ:RCKT) prospects have taken a significant hit on the company being forced to halt research on its experimental gene therapy for Danon Disease. The decision comes ...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=aedf657c169a1afedf03afbb2bd67ae7edcfe3b699913478e73f8eed6db8ceaa" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.89
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) has suspended dosing in its Danon disease gene therapy trial after a patient developed fatal complications from capillary leak syndrome, which caused a sever...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1aa34b8c860854e9dfcc0143e7f220f3fd81a54fa89171f807183bc5cbe69042" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals: Despite FDA Clinical Hold On RP-A501, Prospects Remain Intact</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>SeekingAlpha</span>
                                <span class="article-sentiment positive">
                                    0.37
                                </span>
                            </div>
                            <div class="article-summary">nan...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=bcf926f97933330e3a43d7620dd5b9833fa25efff193251046c2604b2fa863d6" target="_blank" rel="noopener noreferrer">RCKT Stock Tanks on Patient Death in Danon Disease Study</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.89
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals plunges after a patient death in its Danon disease study, prompting a voluntary dosing pause. The FDA puts a clinical hold on the study....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fd8ca8b8c066dd372efcad0c88ddab0d3b9dfe27a96a4eb28675a0350784ad02" target="_blank" rel="noopener noreferrer">William Blair Reaffirms Outperform Rating on Rocket Pharma Despite Trial Setback</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    -0.12
                                </span>
                            </div>
                            <div class="article-summary">Sami Corwin, an analyst at William Blair, maintained his Outperform rating on Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) on May 27 with no price target, despite the company‚Äôs recent difficulties. The b...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=2020964440123756f46688e32bdac9297a210d254b46de30d091723a15a87c92" target="_blank" rel="noopener noreferrer">Rocket Pharma's Gene Therapy Future Clouded By Regulatory Uncertainty</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-28</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.37
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals Inc (NASDAQ:RCKT) on Tuesday announced an update related to RP-A501, its investigational gene therapy for Danon disease, a rare X-linked dominant genetic disorder that manifests...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=23175661603afd7efc29224d32c0855aa99dddf8c5484e9aee92aa136ea71a14" target="_blank" rel="noopener noreferrer">US FDA places clinical hold on Rocket Pharma's gene therapy trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.82
                                </span>
                            </div>
                            <div class="article-summary">The U.S. Food and Drug Administrationplaced a clinical hold on Rocket Pharmaceuticals' genetherapy trial due to a serious event in one patient, the companysaid on Tuesday.(Reporting by Christy......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d35223457a07801c8a0525513351ea829eecda1d8ecbb5cca15d9b1109bf25b5" target="_blank" rel="noopener noreferrer">US FDA pauses gene therapy trial by Rocket Pharma after patient death</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.56
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals saidon Tuesday the U.S. Food and Drug Administration had placed aclinical hold on its mid-stage gene therapy trial after apatient died due to a serious adverse event, sending......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=d85147974fdefe7e1613f709a921b4d639c5b721158cfb4a3f8b7219f935cf88" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals, Inc. Provides Update on Phase 2 Clinical Trial of Rp-A501 for Danon Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.40
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals, Inc. announced an update related to RP-A501, its investigational gene therapy for Danon disease. A patient participating in the Phase 2 pivotal trial of RP-A501 experienced an....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=53bf9c10376f0c38e6995ec0c6cc558e53b05a0d07a6dec3b7a2f9ea6ef5371e" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Shares Down as Trial Patient Dies of Complications</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.97
                                </span>
                            </div>
                            <div class="article-summary">By Adriano Marchese Rocket Pharmaceuticals shares fell sharply in premarket trading Tuesday after a trial for its investigational therapy for Danon disease was halted by regulators following the......</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=26dcd4f815d0564ccbf843ddd6582c07992c7bb4e41fc3ddfea0d5fef28d5ee1" target="_blank" rel="noopener noreferrer">FDA halts Rocket Pharma's gene therapy trial as complications lead to patient death</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment negative">
                                    -0.92
                                </span>
                            </div>
                            <div class="article-summary">The U.S. FDA has paused a mid-stagegene therapy trial by Rocket Pharmaceuticals after apatient suffered serious complications, which ultimately led tothe person's death, the drug developer said on......</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=06a6f56119ed7bf5f79262a5d2c05e46ca581c373f91b7d24c1874d3d07e10c7" target="_blank" rel="noopener noreferrer">Transcript : Rocket Pharmaceuticals, Inc. - Special Call</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">Presentation Operator MessageOperator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the Rocket Pharma Clinical Update Conference Call. [Operator Instructions]. I...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=65285bccb9972245a7f11737405edb17715bdeac0b9de51f69e3481937fee6a3" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.35
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., May 27, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing an integrated pipeline of genetic therapies for rare diseases,...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=301d91d9f0eaf4f71bda093b7f06d292d5861c506bc72bdf60a61c7b5c8bf7d4" target="_blank" rel="noopener noreferrer">Sector Update: Health Care Stocks Rise Premarket Tuesday</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.35
                                </span>
                            </div>
                            <div class="article-summary">Health care stocks were edging higher premarket Tuesday as the Health Care Select Sector SPDR Fund (...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=e4b6f854cd846f3dab6ba00401fa8df6dc3fee8b0080a420b9e7cc6364cb98aa" target="_blank" rel="noopener noreferrer">CoreWeave, Rocket Pharmaceuticals, SoundHound: Trending Tickers</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.56
                                </span>
                            </div>
                            <div class="article-summary">Barclays analysts downgraded CoreWeave (CRWV) to Equal Weight, raising valuation concerns. This is CoreWeave's first downgrade since the company's initial public offering (IPO). Rocket Pharmaceuticals...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b7bfb11161393f6ac505145c856e1803c07fd823e9d24ad017d260bc8280ac2b" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Stock Craters After Gene Therapy Patient Dies</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.58
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals shares plummeted 60% Tuesday after the firm said it halted a study of a gene-therapy drug for Danon disease because a patient had a "Serious Adverse Event (SAE)" and later died....</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=fe6030c3684fb2497b1cacd9d4d2736dfbe8ed44470e64fd259bd1b1807ee58e" target="_blank" rel="noopener noreferrer">Patient dies in Rocket‚Äôs Phase II Danon disease gene therapy trial</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-27</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.46
                                </span>
                            </div>
                            <div class="article-summary">The FDA ordered a clinical hold on the Phase II trial after the adverse event was first disclosed....</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=36f75d754b38e02cab9d316e968470b805f6e8fc4ce04c881d96718c77847196" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of Gene and Cell Therapy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-15</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment positive">
                                    0.55
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., May 15, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders...</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=88fa36ab649b40c109435148c72c56bf6bd4a900e2d07ad1aab2c5f6e8f0c9e3" target="_blank" rel="noopener noreferrer">Is Rocket Pharmaceuticals (RCKT) the Best Low Priced Biotech Stock to Buy Now?</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-13</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">We recently published a list of 10 Best Low Priced Biotech Stocks to Buy Now. In this article, we are going to take a look at where Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) stands against other best...</div>
                        </div>
                    </div>
            
                    <div class="article-card positive">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=203c01ec7851e9768b58a78362eeb88c4ed791827d309fd36e73ca0671c09eec" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Announces Late-Breaking Oral Presentation of Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy Accepted at 28th Annual Meeting of the American Society of Gene and Cell Therapy</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-12</span>
                                <span>Finnhub</span>
                                <span class="article-sentiment positive">
                                    0.46
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J. - Rocket Pharmaceuticals, Inc., a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=f2e9c42209fe061c1264c466a4acdc72735a628f2518e2242abb469745133130" target="_blank" rel="noopener noreferrer">RCKT's Q1 Loss Narrower Than Expected, Pipeline in Focus</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-09</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.94
                                </span>
                            </div>
                            <div class="article-summary">Rocket Pharmaceuticals incurs a narrower-than-expected first-quarter 2025 loss. The company provides updates on its pipeline candidates....</div>
                        </div>
                    </div>
            
                    <div class="article-card neutral">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=b0d60cb66b308d0ab91d49e99821395bf1e128d573ea5fb288e03c184e87b8f3" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals Reports First Quarter 2025 Financial Results and Highlights Recent Progress</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment neutral">
                                    0.00
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J., May 08, 2025--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders...</div>
                        </div>
                    </div>
            
                    <div class="article-card negative">
                        <div class="article-content">
                            <h3 class="article-title">
                                <a href="https://finnhub.io/api/news?id=1bb58c581b4d5a8db5a0c93e005868ae0f11a1b76487fec2fb8dc1665e1419c3" target="_blank" rel="noopener noreferrer">Rocket Pharmaceuticals: Q1 Earnings Snapshot</a>
                            </h3>
                            <div class="article-meta">
                                <span>2025-05-08</span>
                                <span>Yahoo</span>
                                <span class="article-sentiment negative">
                                    -0.76
                                </span>
                            </div>
                            <div class="article-summary">CRANBURY, N.J. (AP) ‚Äî Rocket Pharmaceuticals Inc. RCKT) on Thursday reported a loss of $61.3 million in its first quarter. The Cranbury, New Jersey-based company said it had a loss of 56 cents per sha...</div>
                        </div>
                    </div>
            
                </div>
            </div>
        </body>
        </html>
        